Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

  1. Soria-Juan, B.
  2. Garcia-Arranz, M.
  3. Llanos Jiménez, L.
  4. Aparicio, C.
  5. Gonzalez, A.
  6. Mahillo Fernandez, I.
  7. Riera del Moral, L.
  8. Grochowicz, L.
  9. Andreu, E.J.
  10. Marin, P.
  11. Castellanos, G.
  12. Moraleda, J.M.
  13. García-Hernández, A.M.
  14. Lozano, F.S.
  15. Sanchez-Guijo, F.
  16. Villarón, E.M.
  17. Parra, M.L.
  18. Yañez, R.M.
  19. de la Cuesta Diaz, A.
  20. Tejedo, J.R.
  21. Bedoya, F.J.
  22. Martin, F.
  23. Miralles, M.
  24. del Rio Sola, L.
  25. Fernández-Santos, M.E.
  26. Ligero, J.M.
  27. Morant, F.
  28. Hernández-Blasco, L.
  29. Andreu, E.
  30. Hmadcha, A.
  31. Garcia-Olmo, D.
  32. Soria, B.
  33. Montrer des auteurs +
Revue:
Trials

ISSN: 1745-6215

Année de publication: 2021

Volumen: 22

Número: 1

Type: Article

DOI: 10.1186/S13063-021-05430-2 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus